As much as the Affordable Care Act was a tough pill to swallow for many conservatives, the flexible spending account changes may be the first piece of what many consider to be "bad medicine" to be reversed this year. Incentivizing self-care is better medicine for all constituents.
Sam's Club pharmacies, which ranked highest among retailers in the prescription ordering and pickup process category in the J.D. Power and Associates 2010 U.S. National Pharmacy Study, is expanding its services this month.
The news that Shoppers Drug Mart president and CEO Jürgen Schreiber is stepping down has taken investors and many industry observers by surprise; the reality is that the company has been wading through some corporate-level changes in recent years, and the Canadian retail market is facing its fair share of competitive challenges.
Though Schering-Plough’s — now Merck’s — Claritin and Johnson & Johnson’s Zyrtec product lines have dominated the over-the-counter antihistamine market, the big share of the prescription antihistamine market held by Sanofi-Aventis’ Allegra (fexofenadine hydrochloride) could give it a battering ram to bust in as well, thanks to the big break Sanofi got in the form of a Food and Drug Administration approval of an OTC switch for the drug.